DK0730444T3 - Præparater med opretholdt frigivelse til 24-timers frigivelse af metoprolol. - Google Patents

Præparater med opretholdt frigivelse til 24-timers frigivelse af metoprolol.

Info

Publication number: DK0730444T3
Authority: DK; Denmark
Prior art keywords: metoprolol; release; sustained; sustained release; hour
Prior art date: 1993-11-12

Application number

DK94931991T

Other languages

Danish (da)

English (en)

Inventor

Anand R Baichwal

John N Staniforth

Original Assignee

Penwest Pharmaceuticals Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-11-12

Filing date

1994-10-19

Publication date

2003-04-14

1994-10-19 Application filed by Penwest Pharmaceuticals Co filed Critical Penwest Pharmaceuticals Co

2003-04-14 Application granted granted Critical

2003-04-14 Publication of DK0730444T3 publication Critical patent/DK0730444T3/da

Links

IUBSYMUCCVWXPE-UHFFFAOYSA-N metoprolol Chemical compound COCCC1=CC=C(OCC(O)CNC(C)C)C=C1 IUBSYMUCCVWXPE-UHFFFAOYSA-N 0.000 title abstract 4
229960002237 metoprolol Drugs 0.000 title abstract 4
239000003405 delayed action preparation Substances 0.000 title 1
238000013268 sustained release Methods 0.000 abstract 3
239000012730 sustained-release form Substances 0.000 abstract 3
125000002091 cationic group Chemical group 0.000 abstract 1
239000003431 cross linking reagent Substances 0.000 abstract 1
238000009472 formulation Methods 0.000 abstract 1
239000003349 gelling agent Substances 0.000 abstract 1
230000002209 hydrophobic effect Effects 0.000 abstract 1
239000000463 material Substances 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
239000008184 oral solid dosage form Substances 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
239000008024 pharmaceutical diluent Substances 0.000 abstract 1
239000000546 pharmaceutical excipient Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

DK94931991T 1993-11-12 1994-10-19 Præparater med opretholdt frigivelse til 24-timers frigivelse af metoprolol. DK0730444T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US08/151,272 US5399358A (en)	1993-11-12	1993-11-12	Sustained release formulations for 24 hour release of metroprolol
PCT/US1994/012139 WO1995013055A1 (fr)	1993-11-12	1994-10-19	Formulations de liberation prolongee de metoprolol pendant 24 heures

Publications (1)

Publication Number	Publication Date
DK0730444T3 true DK0730444T3 (da)	2003-04-14

Family

ID=22538025

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK94931991T DK0730444T3 (da)	1993-11-12	1994-10-19	Præparater med opretholdt frigivelse til 24-timers frigivelse af metoprolol.

Country Status (16)

Country	Link
US (1)	US5399358A (fr)
EP (1)	EP0730444B1 (fr)
JP (1)	JP2832248B2 (fr)
KR (1)	KR100197841B1 (fr)
CN (1)	CN1198596C (fr)
AT (1)	ATE230980T1 (fr)
AU (1)	AU675370B2 (fr)
CA (1)	CA2171844C (fr)
DE (1)	DE69432025T2 (fr)
DK (1)	DK0730444T3 (fr)
ES (1)	ES2191034T3 (fr)
FI (1)	FI116450B (fr)
HU (1)	HU223612B1 (fr)
IL (1)	IL111400A (fr)
TW (1)	TW314469B (fr)
WO (1)	WO1995013055A1 (fr)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5773025A (en) *	1993-09-09	1998-06-30	Edward Mendell Co., Inc.	Sustained release heterodisperse hydrogel systems--amorphous drugs
IS1736B (is) *	1993-10-01	1999-12-30	Astra Ab	Aðferð og tæki sem stuðla að aukinni samloðun agna
US5399362A (en) *	1994-04-25	1995-03-21	Edward Mendell Co., Inc.	Once-a-day metoprolol oral dosage form
WO1995028916A1 (fr) *	1994-04-25	1995-11-02	Edward Mendell Co., Inc.	Excipient a liberation prolongee
AU2068797A (en) *	1996-01-29	1997-08-20	Edward Mendell Co. Inc.	Sustained release excipient
TW486370B (en) *	1996-12-25	2002-05-11	Yamanouchi Pharma Co Ltd	Rapidly disintegrable pharmaceutical composition
IN186245B (fr)	1997-09-19	2001-07-14	Ranbaxy Lab Ltd
JP4234803B2 (ja) *	1997-10-27	2009-03-04	久光製薬株式会社	薬物放出速度が制御された医薬組成物
CN1228043C (zh) *	1999-09-30	2005-11-23	爱德华·孟岱尔股份有限公司	用于高溶解度药物的缓释基质
AP1748A (en) *	2001-03-13	2007-06-11	Penwest Pharmaceuticals Co	Chronotherapeutic dosage forms.
JP2005515966A (ja) *	2001-07-06	2005-06-02	エンドーファーマシューティカルズ，インコーポレイティド	鎮痛薬としての使用のための６−ヒドロキシ−オキシモルホンの経口投与
DE60223254T2 (de) *	2001-07-06	2008-08-14	Penwest Pharmaceuticals Co.	Verzögert freisetzende formulierungen von oxymorphon
AU2002337686B2 (en) *	2001-09-26	2008-05-15	Penwest Pharmaceuticals Company	Opioid formulations having reduced potential for abuse
US6635675B2 (en)	2001-11-05	2003-10-21	Cypress Bioscience, Inc.	Method of treating chronic fatigue syndrome
CN1642532A (zh) *	2002-03-22	2005-07-20	西拉格股份公司	曲马多缓释制剂
EP1499295A4 (fr) *	2002-04-05	2006-04-05	Penwest Pharmaceuticals Co	Formulations de metoprolol a liberation prolongee
JP2005537298A (ja) *	2002-08-02	2005-12-08	ペンウェストファーマシューティカルズカンパニー	メトホルミンの徐放性製剤
US6936574B2 (en) *	2002-08-30	2005-08-30	Halliburton Energy Services, Inc.	Process for controlling gas migration during well cementing
US7314640B2 (en) *	2003-07-11	2008-01-01	Mongkol Sriwongjanya	Formulation and process for drug loaded cores
US20050032879A1 (en) *	2003-08-07	2005-02-10	Temple Okarter	Formulations and use of a beta-blocker and an ACE-inhibitor for the treatment of cardiovascular diseases
US8389008B2 (en) *	2003-09-19	2013-03-05	Penwest Pharmaceuticals Co.	Delayed release dosage forms
MXPA06003101A (es) *	2003-09-19	2006-06-20	Penwest Pharmaceuticals Co	Formas de dosis cronoterapeuticas.
CA2556220A1 (fr) *	2004-02-11	2005-08-25	Athpharma Limited	Compositions chronotherapeutiques et procedes d'utilisation
US20060105044A1 (en) *	2004-05-20	2006-05-18	Singh Bramah N	Sustained release formulations of sotalol
US8394812B2 (en)	2005-08-24	2013-03-12	Penwest Pharmaceuticals Co.	Sustained release formulations of nalbuphine
EP1931315B1 (fr)	2005-08-24	2013-10-16	Penwest Pharmaceuticals Co.	Formulations de nalbuphine a liberation prolongee
US20070053983A1 (en) *	2005-09-06	2007-03-08	Girish Jain	Extended release compositions of metoprolol succinate
US20070092573A1 (en) *	2005-10-24	2007-04-26	Laxminarayan Joshi	Stabilized extended release pharmaceutical compositions comprising a beta-adrenoreceptor antagonist
WO2007059372A2 (fr) *	2005-11-09	2007-05-24	St. Jude Children's Research Hospital	Utilisation de chloroquine en vue de traiter un syndrome metabolique
US8691272B2 (en) *	2005-12-30	2014-04-08	Intelgenx Corp.	Multilayer tablet
US20070212414A1 (en) *	2006-03-08	2007-09-13	Penwest Pharmaceuticals Co.	Ethanol-resistant sustained release formulations
US8124598B2 (en) *	2006-09-14	2012-02-28	Sharon Sageman	7-keto DHEA for psychiatric use
EP2067475A4 (fr)	2006-09-26	2010-12-15	Astellas Pharma Inc	Préparation à libération entretenue de tacrolimus
US20080085304A1 (en) *	2006-10-10	2008-04-10	Penwest Pharmaceuticals Co.	Robust sustained release formulations
US20080085303A1 (en) *	2006-10-10	2008-04-10	Penwest Pharmaceuticals Co.	Robust sustained release formulations of oxymorphone and methods of use thereof
US20080085305A1 (en) *	2006-10-10	2008-04-10	Penwest Pharmaceuticals Co.	Robust sustained release formulations of oxymorphone
US20090011018A1 (en) *	2006-12-28	2009-01-08	Astellas Pharma Inc.,	Sustained release formulation for tacrolimus
US20100160274A1 (en) *	2007-09-07	2010-06-24	Sharon Sageman	7-KETO DHEA for Psychiatric Use
MX2011001384A (es)	2008-08-06	2011-09-27	Gosforth Ct Holdings Pty Ltd	Composiciones y metodos para tratar trastornos psiquiatricos.
WO2010099508A1 (fr)	2009-02-26	2010-09-02	Theraquest Biosciences, Inc.	Compositions pharmaceutiques orales à libération prolongée de 3-hydroxy-n-méthylmorphinane et procédé d'utilisation
DK2255791T3 (da) *	2009-04-03	2012-03-05	Zaklady Farmaceutyczne Polpharma Sa	Forlænget-frigivelse-farmaceutisk sammensætning omfattende metoprololsuccinat
US10610528B2 (en)	2009-12-08	2020-04-07	Intelgenx Corp.	Solid oral film dosage forms and methods for making same
US20110136815A1 (en) *	2009-12-08	2011-06-09	Horst Zerbe	Solid oral film dosage forms and methods for making same
ES2665467T3 (es)	2010-03-29	2018-04-25	Astellas Pharma Inc.	Composición farmacéutica de liberación modificada
GB201111712D0 (en)	2011-07-08	2011-08-24	Gosforth Ct Holdings Pty Ltd	Pharmaceutical compositions
WO2015073736A1 (fr)	2013-11-13	2015-05-21	Arbor Pharmaceuticals, Llc	Méthodes et compositions de traitement du tdah
AU2016288643A1 (en)	2015-07-02	2018-02-22	University Of Louisville Research Foundation, Inc.	Edible plant-derived microvesicle compositions for delivery of miRNA and methods for treatment of cancer

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4303691A (en) *	1977-11-09	1981-12-01	Anderson, Clayton & Co.	Proteinaceous food product
US4309405A (en)	1979-08-09	1982-01-05	American Home Products Corporation	Sustained release pharmaceutical compositions
US4764380A (en) *	1982-03-22	1988-08-16	Alza Corporation	Drug delivery system comprising a volume increasing matrix containing a plurality of tiny pills
US5081154A (en) *	1984-01-10	1992-01-14	Aktiebolaget Hassle	Metoprolol succinate
GB8518301D0 (en) *	1985-07-19	1985-08-29	Fujisawa Pharmaceutical Co	Hydrodynamically explosive systems
SE455836B (sv) *	1985-10-11	1988-08-15	Haessle Ab	Beredning med kontrollerad frisettning innehallande ett salt av metoprolol samt metod for framstellning av denna beredning
US4795642A (en) *	1986-05-01	1989-01-03	Pharmacaps, Inc.	Gelatin-encapsulated controlled-release composition
IT1198449B (it) *	1986-10-13	1988-12-21	F I D I Farmaceutici Italiani	Esteri di alcoli polivalenti di acido ialuronico
GB8628359D0 (en) *	1986-11-27	1986-12-31	Zyma Sa	Galenical formulation
US4968508A (en) *	1987-02-27	1990-11-06	Eli Lilly And Company	Sustained release matrix
US4792452A (en) *	1987-07-28	1988-12-20	E. R. Squibb & Sons, Inc.	Controlled release formulation
US4994276A (en) *	1988-09-19	1991-02-19	Edward Mendell Co., Inc.	Directly compressible sustained release excipient
SE8703881D0 (sv) *	1987-10-08	1987-10-08	Haessle Ab	New pharmaceutical preparation
US4857331A (en) *	1988-03-31	1989-08-15	Warner-Lambert Company	Sugarless pectin delivery system
US5047244A (en) *	1988-06-03	1991-09-10	Watson Laboratories, Inc.	Mucoadhesive carrier for delivery of therapeutical agent
US5135757A (en) *	1988-09-19	1992-08-04	Edward Mendell Co., Inc.	Compressible sustained release solid dosage forms
US5128143A (en) *	1988-09-19	1992-07-07	Edward Mendell Co., Inc.	Sustained release excipient and tablet formulation
US5169639A (en) *	1988-09-19	1992-12-08	Edward Mendell Co., Inc.	Controlled release verapamil tablets
US5032406A (en) *	1989-02-21	1991-07-16	Norwich Eaton Pharmaceuticals, Inc.	Dual-action tablet
US5271943A (en) *	1989-10-27	1993-12-21	Scott Health Care	Wound gel compositions containing sodium chloride and method of using them
US5215756A (en) *	1989-12-22	1993-06-01	Gole Dilip J	Preparation of pharmaceutical and other matrix systems by solid-state dissolution
US5169638A (en) *	1991-10-23	1992-12-08	E. R. Squibb & Sons, Inc.	Buoyant controlled release powder formulation
HU209251B (en) *	1992-03-13	1994-04-28	Synepos Ag	Process for producing stable, peroral solution drug forms with controlled release of active ingredient and comprising beta-blocking pharmacons
US5330761A (en) *	1993-01-29	1994-07-19	Edward Mendell Co. Inc.	Bioadhesive tablet for non-systemic use products
US5455046A (en) *	1993-09-09	1995-10-03	Edward Mendell Co., Inc.	Sustained release heterodisperse hydrogel systems for insoluble drugs

1993
- 1993-11-12 US US08/151,272 patent/US5399358A/en not_active Expired - Lifetime
1994
- 1994-10-19 CA CA002171844A patent/CA2171844C/fr not_active Expired - Fee Related
- 1994-10-19 AU AU80875/94A patent/AU675370B2/en not_active Ceased
- 1994-10-19 KR KR1019960702479A patent/KR100197841B1/ko not_active Expired - Fee Related
- 1994-10-19 ES ES94931991T patent/ES2191034T3/es not_active Expired - Lifetime
- 1994-10-19 WO PCT/US1994/012139 patent/WO1995013055A1/fr not_active Ceased
- 1994-10-19 JP JP7513847A patent/JP2832248B2/ja not_active Expired - Fee Related
- 1994-10-19 DK DK94931991T patent/DK0730444T3/da active
- 1994-10-19 DE DE69432025T patent/DE69432025T2/de not_active Expired - Lifetime
- 1994-10-19 EP EP94931991A patent/EP0730444B1/fr not_active Expired - Lifetime
- 1994-10-19 HU HU9601008A patent/HU223612B1/hu not_active IP Right Cessation
- 1994-10-19 AT AT94931991T patent/ATE230980T1/de not_active IP Right Cessation
- 1994-10-25 IL IL11140094A patent/IL111400A/en not_active IP Right Cessation
- 1994-11-12 CN CNB941200892A patent/CN1198596C/zh not_active Expired - Fee Related
- 1994-11-15 TW TW083110556A patent/TW314469B/zh active
1996
- 1996-05-10 FI FI961996A patent/FI116450B/fi active IP Right Grant

Also Published As

Publication number	Publication date
CN1109328A (zh)	1995-10-04
FI961996A0 (fi)	1996-05-10
ATE230980T1 (de)	2003-02-15
JPH08511807A (ja)	1996-12-10
EP0730444A1 (fr)	1996-09-11
EP0730444A4 (fr)	1996-11-06
DE69432025D1 (de)	2003-02-20
AU675370B2 (en)	1997-01-30
IL111400A0 (en)	1994-12-29
ES2191034T3 (es)	2003-09-01
EP0730444B1 (fr)	2003-01-15
HUT75881A (en)	1997-05-28
FI961996L (fi)	1996-05-29
CN1198596C (zh)	2005-04-27
AU8087594A (en)	1995-05-29
CA2171844C (fr)	2000-05-30
KR100197841B1 (ko)	1999-06-15
WO1995013055A1 (fr)	1995-05-18
HU9601008D0 (en)	1996-06-28
US5399358A (en)	1995-03-21
FI116450B (fi)	2005-11-30
HU223612B1 (hu)	2004-10-28
DE69432025T2 (de)	2003-10-16
CA2171844A1 (fr)	1995-05-18
TW314469B (fr)	1997-09-01
JP2832248B2 (ja)	1998-12-09
IL111400A (en)	1999-03-12

Publication	Publication Date	Title
DK0730444T3 (da)	2003-04-14	Præparater med opretholdt frigivelse til 24-timers frigivelse af metoprolol.
DK0723435T3 (da)	2002-02-11	Oral doseringsform af metoprolol til administration én gang dagligt
DK0804166T3 (da)	2011-08-15	Formulering med kontrolleret frigivelse (Albuterol)
DK0700284T3 (da)	2003-01-06	Oxybutyninformuleringer med kontrolleret frigivelse
ID28003A (id)	2001-05-03	Turunan-turunan adamantana
UA32512C2 (uk)	2001-02-15	Похідні ксантину, спосіб їх одержання, та фармацевтична композиція
NZ264487A (en)	1998-12-23	Tetracycline based prodrug conjugate, pharmaceutical compositions thereof
CA2231195A1 (fr)	1998-01-15	Matrice a liberation prolongee pour medicaments insolubles en doses elevees
SE9704545D0 (sv)	1997-12-05	Novel compounds
NO971206D0 (no)	1997-03-14	Forlenget-frigjöringsformulering
FI932553A7 (fi)	1993-06-04	Uusia farmaseuttisia formulaatioita, jotka sisältävät farmakologisesti aktiivista ionisoitavaa ainetta, sekä menetelmä niiden valmistamiseksi
GR3025951T3 (en)	1998-04-30	Alpha amino acid derivatives, a method for their preparation and pharmaceutical preparations containing them.
IT1269508B (it)	1997-04-01	Procedimento per la preparazione di particelle lavorate a secco, particelle lavorate a secco cosi' ottenute e composizioni farmaceutiche contenenti le particelle
ES2185666T3 (es)	2003-05-01	Formulacion estabilizada para comprimidos.
DK221288A (da)	1988-10-24	2beta-,16beta-diamino-androstaner og fremgangsmaade til fremstilling deraf samt farmaceutisk middel indeholdende en saadan forbindelse
GEP20012518B (en)	2001-08-27	Novel Erythromycin Derivatives, Method for Their Preparation and Their Use as Medicine
IT1252867B (it)	1995-06-28	Composizioni farmaceutiche contenenti progesterone ad elevata biodisponibilita'